These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 15068834
21. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer. Dachineni R, Kumar DR, Callegari E, Kesharwani SS, Sankaranarayanan R, Seefeldt T, Tummala H, Bhat GJ. Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787 [Abstract] [Full Text] [Related]
22. L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma. Ma Q, Wang Y, Gao X, Ma Z, Song Z. Clin Cancer Res; 2007 Dec 15; 13(24):7407-12. PubMed ID: 18094424 [Abstract] [Full Text] [Related]
23. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma. Kunimoto Y, Nakamura T, Ohno M, Kuroda Y. Oncol Rep; 2004 Dec 15; 12(6):1163-7. PubMed ID: 15547732 [Abstract] [Full Text] [Related]
24. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K, Pryczynicz A, Kemona A, Czyzewska J. Anticancer Res; 2009 Aug 15; 29(8):3049-52. PubMed ID: 19661314 [Abstract] [Full Text] [Related]
25. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators. Macrae FA, Kilias D, Sharpe K, Hughes N, Young GP, MacLennan R. J Cell Biochem Suppl; 1994 Aug 15; 19():84-90. PubMed ID: 7823610 [Abstract] [Full Text] [Related]
26. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Gill S, Sinicrope FA. Semin Oncol; 2005 Feb 15; 32(1):24-34. PubMed ID: 15726503 [Abstract] [Full Text] [Related]
27. Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer. Miyamoto S, Ito K, Kurokawa K, Suzuki K, Suzuki K, Yamanaka H. Int J Urol; 2006 Jun 15; 13(6):767-72. PubMed ID: 16834658 [Abstract] [Full Text] [Related]
28. Expression of gamma-aminobutyric acid and glutamic acid decarboxylases in rat descending colon and their relation to epithelial differentiation. Wang FY, Zhu RM, Maemura K, Hirata I, Katsu K, Watanabe M. Chin J Dig Dis; 2006 Jun 15; 7(2):103-8. PubMed ID: 16643338 [Abstract] [Full Text] [Related]
30. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E. Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860 [Abstract] [Full Text] [Related]
32. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci. Ziliotto L, Barbisan LF, Rodrigues MA. Hum Exp Toxicol; 2008 Jun 15; 27(6):505-11. PubMed ID: 18784204 [Abstract] [Full Text] [Related]
33. Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Hoh C, Boocock D, Marczylo T, Singh R, Berry DP, Dennison AR, Hemingway D, Miller A, West K, Euden S, Garcea G, Farmer PB, Steward WP, Gescher AJ. Clin Cancer Res; 2006 May 01; 12(9):2944-50. PubMed ID: 16675592 [Abstract] [Full Text] [Related]
34. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer. Huh JW, Kim HR, Kim YJ. Ann Surg Oncol; 2009 Jun 01; 16(6):1494-500. PubMed ID: 19267156 [Abstract] [Full Text] [Related]